Shopping Cart
Remove All
Your shopping cart is currently empty
UC-1V150
😃Good
Catalog No. T61110Cas No. 927822-45-5
UC-1V150 is a distinct TLR7 agonist, which activates cellular immune responses and exhibits anti-tumor effects. It also serves as a precursor for the synthesis of ISAC molecules, known as immune-stimulating antibody conjugates [1] [2].
UC-1V150
😃Good
Catalog No. T61110Cas No. 927822-45-5
UC-1V150 is a distinct TLR7 agonist, which activates cellular immune responses and exhibits anti-tumor effects. It also serves as a precursor for the synthesis of ISAC molecules, known as immune-stimulating antibody conjugates [1] [2].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | UC-1V150 is a distinct TLR7 agonist, which activates cellular immune responses and exhibits anti-tumor effects. It also serves as a precursor for the synthesis of ISAC molecules, known as immune-stimulating antibody conjugates [1] [2]. |
| In vitro | UC-1V150, at concentrations ranging from 0.01 to 10 μM over a 24-hour period, effectively promotes the secretion of IL-6 and IL-2 cytokines in bone-marrow-derived macrophages [1]. Additionally, when administered at 1 μg/mL for 48 hours, it enhances the expression of FcγRIIA and FcγRIII and induces a roughly 1.5-fold enhancement in the phagocytosis index of target cells in human monocyte-derived macrophages (hMDM) [2]. |
| In vivo | UC-1V150, administered via a single intravenous injection at concentrations ranging from 0.38-38 nM for 2 hours, effectively triggers the release of serum cytokines in female C57BL/6 mice aged 5-6 weeks. This administration resulted in serum interleukin-6 (IL-6) levels reaching approximately 0.1 ng/mL and interleukin-2 (IL-2) levels reaching approximately 1.5 ng/mL at the 38 nM concentration. |
| Molecular Weight | 343.34 |
| Formula | C16H17N5O4 |
| Cas No. | 927822-45-5 |
| Smiles | C(N1C=2C(NC1=O)=C(N)N=C(OCCOC)N2)C3=CC=C(C=O)C=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy UC-1V150 | purchase UC-1V150 | UC-1V150 cost | order UC-1V150 | UC-1V150 chemical structure | UC-1V150 in vivo | UC-1V150 in vitro | UC-1V150 formula | UC-1V150 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.